Aiping Pharm Inc Company Profile
What is the competitive landscape for AIPING PHARM INC
AIPING PHARM INC has fifty-four approved drugs.
Summary for Aiping Pharm Inc
| US Patents: | 0 |
| Tradenames: | 49 |
| Ingredients: | 47 |
| NDAs: | 54 |
Drugs and US Patents for Aiping Pharm Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aiping Pharm Inc | GUANFACINE HYDROCHLORIDE | guanfacine hydrochloride | TABLET;ORAL | 216399-002 | Jun 8, 2022 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Aiping Pharm Inc | ARIPIPRAZOLE | aripiprazole | TABLET;ORAL | 091279-005 | Jan 9, 2017 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Aiping Pharm Inc | ESCITALOPRAM OXALATE | escitalopram oxalate | TABLET;ORAL | 077512-003 | Sep 12, 2012 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Aiping Pharm Inc | METOCLOPRAMIDE HYDROCHLORIDE | metoclopramide hydrochloride | TABLET;ORAL | 072215-001 | Jan 30, 1990 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Aiping Pharm Inc | WARFARIN SODIUM | warfarin sodium | TABLET;ORAL | 200104-006 | Jun 27, 2013 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
